Physician Growth Partners Advises Digestive Disease Consultants in a Partnership With One GI
January 19, 2022 09:00 ET
|
Physician Growth Partners
CHICAGO, Jan. 19, 2022 (GLOBE NEWSWIRE) -- Physician Growth Partners ("PGP") is proud to have advised Digestive Disease Consultants ("DDC" or "the Practice") in a transaction with One GI, a private...
Ritter Pharmaceuticals Highlights Key Phase 2b Clinical Trial Data of RP-G28 for Lactose Intolerance at Digestive Disease Week 2018
June 05, 2018 08:30 ET
|
Ritter Pharmaceuticals, Inc.
Additional Data Describes Novel Clinical Symptom Assessment Tool Developed in Phase 2b Trial and to be Used in Upcoming Phase 3 Clinical Trial LOS ANGELES, June 05, 2018 (GLOBE NEWSWIRE) -- Ritter...
Crinetics Pharmaceuticals Awarded Two SBIR Grants to Develop New Therapeutics for Congenital Hyperinsulinism and Cushing’s Disease
September 06, 2017 09:00 ET
|
Crinetics Pharmaceuticals, Inc.
SAN DIEGO, Sept. 06, 2017 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc., a rare disease therapeutics company focused on endocrine disorders and endocrine-related cancers, announced today that...